Danny Prosky - 12 Mar 2026 Form 4 Insider Report for American Healthcare REIT, Inc. (AHR)

Role
Director
Signature
/s/ DANNY PROSKY
Issuer symbol
AHR
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 16:27:36 UTC
Previous filing
11 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Prosky Danny Director 18191 VON KARMAN AVENUE, THIRD FLOOR, IRVINE /s/ DANNY PROSKY 16 Mar 2026 0001433671

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AHR Common Stock Options Exercise +31,846 +11% 330,881 12 Mar 2026 Direct F1
transaction AHR Common Stock Tax liability -17,181 -5.2% $52.80* 313,700 12 Mar 2026 Direct F2
holding AHR Common Stock 201,403 12 Mar 2026 By Danny and Zohar Prosky Family Rev Trust UA DTD 08/16/2011 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AHR Restricted Stock Unit Award +31,846 $0.000000* 31,846 12 Mar 2026 Common Stock 31,846 Direct F1, F4
transaction AHR Restricted Stock Unit Options Exercise -31,846 -100% $0.000000* 0 12 Mar 2026 Common Stock 31,846 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit converts into one share of the Issuer's common stock.
F2 Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of performance-based restricted stock units ("PRSUs") on March 12, 2026.
F3 The reported shares are held directly by Danny & Zohar Prosky Family Rev Trust UA DTD 08/16/2011, and indirectly by Danny Prosky and Zohar Prosky, Trustees.
F4 These PRSUs were granted without cash consideration on April 3, 2023 under the Issuer's Second Amended and Restated 2015 Incentive Plan. The performance goals of such PRSUs were confirmed as having been met on March 12, 2026, on which date such PRSUs vested in full.

Remarks:

The Reporting Person is currently on a medical leave of absence during which time he is not serving as the Issuer's Chief Executive Officer and President. However, he continues to serve in his capacity as a director of the Issuer.